MICHL-trial: Impact of Peritoneal Bladder Flap in RARP Patients on Lymphoceles

February 21, 2024 updated by: Martini-Klinik am UKE GmbH

Prospective Randomised Study to Examine the Influence of a Modification of the DaVinci Prostatectomy on the Frequency of Postoperative Lymphoceles Requiring Treatment and Postoperative Complications

A two-armed prospective randomised, controlled, single-centre trial on 1080 patients with prostate cancer who underwent robot-assisted radical prostatectomy with bilateral pelvic lymph node dissection was carried out. Patients in the intervention arm received fixation of the peritoneal flap of the bladder to the plexus Santorini at the end of surgery (Michl-technique, MT); in the control group, surgery was performed without this modification. The primary endpoint was the rate of lymphoceles requiring intervention.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

1080

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hamburg, Germany, 20246
        • Martini-Klinik am UKE GmbH

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Declaration of consent signed
  • Minimum age 18 years
  • localised prostate carcinoma
  • planned DVRP with bilateral lymphadenectomy

Exclusion Criteria:

  • patient's lack of capacity to consent
  • ORP
  • no planned PLND
  • metastatic prostate cancer
  • ASA status >3

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: control
Experimental: Michl-stitch
In the intervention group, a ventral fixation was performed by suturing the ventral bladder peritoneum to the plexus Santorini and from there to the right and left lateral endopelvic fascia (MICHL-stitch).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
rate of lymphoceles requiring intervention after RARP
Time Frame: one year follow-up
Clavien-Dindo >2°
one year follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
total lymphocele rate after RARP
Time Frame: one year follow-up
Clavien-Dindo
one year follow-up
other complications ≥ grade IIIa according to Clavien-Dindo after RARP
Time Frame: one year follow-up
Clavien-Dindo
one year follow-up
continence rates after RARP
Time Frame: one year folow-up
EPIC
one year folow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Uwe Michl, Martini-Klinik am UKE GmbH

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 19, 2017

Primary Completion (Actual)

October 16, 2019

Study Completion (Actual)

May 31, 2021

Study Registration Dates

First Submitted

February 14, 2024

First Submitted That Met QC Criteria

February 21, 2024

First Posted (Actual)

February 28, 2024

Study Record Updates

Last Update Posted (Actual)

February 28, 2024

Last Update Submitted That Met QC Criteria

February 21, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2017-PS-03
  • PV6099 (Other Identifier: Martini-Klinik)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

A publication in a peer-reviewed journal is planned

IPD Sharing Time Frame

after final analysis

IPD Sharing Access Criteria

peer-reviewed journal

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lymphocele After Surgical Procedure

Clinical Trials on Michl-stitch

Subscribe